Clinical Trial Update: Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing cathelicidin and vitamin D effects in at-risk populations and individuals with chronic obstructive pulmonary disease (COPD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Vitamin D (Cholecalciferol)
• cathelicidin (cathelicidin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2020-07-24